Randy Meier

Richard A. Meier is currently Co-Managing Director at Intersect ENT International GmbH and Intersect ENT GmbH, Member of the Supervisory Board at Syntellix AG, and Partner at Atlas Rock Co. Former roles include President, Chief Executive Officer & Director at Rockley Photonics Holdings Ltd. (2022–2023); Chairman at BioMarin Pharmaceutical, Inc. (2006–2026); Independent Director at STAAR Surgical Co. (2011–2016); Principal at Greyhound Lines, Inc., Australian Capital Equity Pty Ltd., Manufacturers Hanover Corp., and Salomon Smith Barney, Inc.; Chief Financial Officer & Executive Vice President at Bausch Health Americas, Inc. (1999); CFO, Executive VP & President-International at Accendra Health, Inc. (2015–2018); Chief Financial Officer & Executive Vice President at Teleflex, Inc. (2010–2011); Senior Vice President at Schroder & Co., Inc. (1996–1998); President & Chief Operating Officer at Advanced Medical Optics, Inc. (2007–2009); and Chief Financial Officer & Executive Vice President at Intersect ENT, Inc. (2019–2022).
Education includes undergraduate studies at Princeton University.